Phosphotech and Enzymotec Sign Marketing Agreement

Article

Phosphotech (Saint-Herblain Cedex, France) and Enzymotec (Springfield, NJ) have signed a marketing agreement to target the nutraceutical market in France.

Phosphotech (Saint-Herblain Cedex, France) and Enzymotec (Springfield, NJ) have signed a marketing agreement to target the nutraceutical market in France.

Phosphotech specializes in natural ingredient for human and animal health. They will will distribute phosphatidylserine-based products under the Sharp trademark.

“We expect that the collaboration with Phosphotech will enable us to deepen our penetration into the French market which is one of leading nutraceutical markets in Europe. The collaboration will cover our proprietary phospholipids based line of cognitive solutions under the brand name Sharp. The French nutraceuticals brands have a very strong presence in other European countries and we expect that working closely with leading French companies will further expand our market share in the European market,” said Michal Haim-Bravman, Enzymotec's director of sales and marketing.

Related Videos
Nils Hoem and Nutritional Outlook editor Sebastian Krawiec
Related Content
© 2024 MJH Life Sciences

All rights reserved.